Kingdon Capital Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Kingdon Capital Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300,000	Closed	-$3.02M	–	75
2022 Q4	$3.02M	Hold	300,000	–	–	0.6%	40
2022 Q3	$2.97M	Hold	300,000	–	–	0.38%	41
2022 Q2	$2.93M	Hold	300,000	–	–	0.5%	47
2022 Q1	$2.93M	Hold	300,000	–	–	0.31%	62
2021 Q4	$2.92M	Hold	300,000	–	–	0.34%	59
2021 Q3	$2.92M	Hold	300,000	–	–	0.36%	48
2021 Q2	$2.9M	Buy	+300,000	New	+$2.93M	0.34%	55

Kingdon Capital Management's MSAC Position: Q1 2023 in Review

Kingdon Capital Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 300,000 shares — an estimated $3.02M sold.

Kingdon Capital Management first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $3.02M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Kingdon Capital Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Kingdon Capital Management sold 300,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $3.02M.
Kingdon Capital Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Kingdon Capital Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $3.02M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Kingdon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.